Hdac10 Rat Pre-designed siRNA Set A contains three designed siRNAs for Hdac10 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDAC11 Human Pre-designed siRNA Set A contains three designed siRNAs for HDAC11 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac11 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hdac11 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac11 Rat Pre-designed siRNA Set A contains three designed siRNAs for Hdac11 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDAC2 Human Pre-designed siRNA Set A contains three designed siRNAs for HDAC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hdac2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDAC2 Rat Pre-designed siRNA Set A contains three designed siRNAs for HDAC2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDAC3 Human Pre-designed siRNA Set A contains three designed siRNAs for HDAC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hdac3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Hdac3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDAC4 Human Pre-designed siRNA Set A contains three designed siRNAs for HDAC4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hdac4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Hdac4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDAC5 Human Pre-designed siRNA Set A contains three designed siRNAs for HDAC5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hdac5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Hdac5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDAC6 Human Pre-designed siRNA Set A contains three designed siRNAs for HDAC6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac6 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hdac6 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDAC6 Rat Pre-designed siRNA Set A contains three designed siRNAs for HDAC6 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDAC6-IN-32 (compound 25202) is a selective and potent inhibitor of HDAC6. HDAC6-IN-32 blocks HDAC6 activity and interferes with microtubule dynamics, leading to SAC activation and prolonged mitotic arrest, ultimately leading to apoptosis in CRPC cells[1].

HDAC6-IN-33 (compound 6) is a selective and irreversible HDAC6 inhibitor with an IC50 of 193 nM. HDAC6-IN-33 shows no activity against HDAC1-4. HDAC6-IN-33 is a tight-binding HDAC6 inhibitor capable of inhibiting HDAC6 via a two-step slow-binding mechanism[1].

HDAC6-IN-34 (compound 21) is an oral active and selective HDAC6 inhibitor with the IC50 of 18 nM. HDAC6-IN-34 increases the acetylation level of tubulin without affecting histone acetylation in cutaneous T-cell lymphoma cells and inhibits TNF-α secretion in LPS (HY-D1056)-stimulated macrophage cells. HDAC6-IN-34 shows excellent anti-arthritic efficacy in rat[1].

HDAC6-IN-35 (compound C4 (ZINC000077541942)) is a potent and BBB-penetrated HDAC6 inhibitor with the IC50 of 4.7 μM. HDAC6-IN-35 shows cell toxicity against MDA-MB-231 with EC50 of 40.6 μM[1].

HDAC6-IN-36 (compound 11d) is an inhibitor of HDAC6 with IC50 value of 8.64 nM. HDAC6-IN-36 induces neurite outgrowth of PC12 cells without producing toxic effects.

HDAC6-IN-37 (compound W5) is an inhibitor of HDAC6 and has neuroprotective effects. HDAC6-IN-37 can restore the morphology of hippocampal neurons, reduce the expression of Aβ, Tau, and p-Tau proteins in the hippocampus of AD rats, and inhibit the formation of senile plaques and neurofibrillary tangles. Thus, HDAC6-IN-37 improves the Aβ/Cu2+-induced AD model in rats, regulates […]

HDAC6-IN-38 (Compound Z-7) is an inhibitor for histone deacetylase 6 (HDAC6), with an IC50 of 3.25 nM. HDAC6-IN-38 inhibits proliferation of cells MGC‑803[1].

HDAC6-IN-41 (Compound E24) is a selective inhibitor for histone deacetylase 6 (HDAC6), with IC50 of 14 and 422 nM, for HDAC6 and HDAC8, respectively. HDAC6-IN-41 upregulates the acetylation of α-tubulin and histone site SMC3[1].

HDAC7 Human Pre-designed siRNA Set A contains three designed siRNAs for HDAC7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac7 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hdac7 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac7 Rat Pre-designed siRNA Set A contains three designed siRNAs for Hdac7 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDAC8 Human Pre-designed siRNA Set A contains three designed siRNAs for HDAC8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac8 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hdac8 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDAC8 Rat Pre-designed siRNA Set A contains three designed siRNAs for HDAC8 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDAC8-IN-7 (H7E), a HDAC8 inhibitor, exerts retinoprotective effects against glaucomatous injury via ameliorating aberrant Müller glia activation and oxidative stress. HDAC8-IN-7 alleviates functional and structural defects within the inner retina[1].

HDAC9 Human Pre-designed siRNA Set A contains three designed siRNAs for HDAC9 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Hdac9 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Hdac9 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDAC9 Rat Pre-designed siRNA Set A contains three designed siRNAs for HDAC9 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDC Human Pre-designed siRNA Set A contains three designed siRNAs for HDC gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDDC2 Human Pre-designed siRNA Set A contains three designed siRNAs for HDDC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDDC3 Human Pre-designed siRNA Set A contains three designed siRNAs for HDDC3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDGF Human Pre-designed siRNA Set A contains three designed siRNAs for HDGF gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDGFL2 Human Pre-designed siRNA Set A contains three designed siRNAs for HDGFL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDGFL3 Human Pre-designed siRNA Set A contains three designed siRNAs for HDGFL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDHD2 Human Pre-designed siRNA Set A contains three designed siRNAs for HDHD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDHD3 Human Pre-designed siRNA Set A contains three designed siRNAs for HDHD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

HDL-16 is a potent P2Y14R antagonist with an IC50 of 0.3095 nM. HDL-16 ameliorates DSS (HY-116282C)-induced colitis through suppressing necroptosis of intestinal epithelium cells (IECs) and protecting mucosal barrier function[1].